Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.
In addition to our efforts in Australia, Trajan is also progressively certifying all global manufacturing operations. This started at our site in Penang, Malaysia in January 2021 and our US facility in Austin is scheduled to be audited later this year.
Rick Barber PhD, Chief Corporate Systems Officer at Trajan Scientific and Medical, said: "Over the past three years, Trajan has significantly invested resources into developing its Quality Management System to set up the business for scalability and growth. The favourable audit outcome this week is the result of that investment and validates that Trajan has its QMS framework right. Further, it demonstrates the successful establishment of a Quality culture across all functions that is being deployed globally.”
ISO 9001 is the international standard used by organizations to demonstrate their ability to consistently provide products and services that meet customer and regulatory requirements and to demonstrate continuous improvement. Customers benefit by receiving products/services that meet their requirements, with consistent performance. Internally, the organization profits from increased job satisfaction, improved morale, and improved operational results.
Trajan is an Australian headquartered global developer and manufacturer of analytical and life sciences products and devices founded to have a positive impact on human wellbeing through scientific measurement. These products and solutions are used in the analysis of biological, food, water, and other environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralized, personalized data-based healthcare.
Trajan is a global organization of 450 people, with five manufacturing sites across the US, Australia, and Malaysia, and an operational footprint with operations in Australia, the US, Asia, and Europe.
Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration with the University of Tasmania where the objective was to develop a range of “lab-in-a-syringe” applications, expanding on Trajan’s expertise in precision manufacturing of their industry leading analytical syringe portfolio.